Airway surface fluid volume and Cl content in cystic fibrosis and normal bronchial xenografts
- PMID: 9950775
- DOI: 10.1152/ajpcell.1999.276.2.C469
Airway surface fluid volume and Cl content in cystic fibrosis and normal bronchial xenografts
Abstract
We describe the use of an in vivo human bronchial xenograft model of cystic fibrosis (CF) and non-CF airways to investigate pathophysiological alterations in airway surface fluid (ASF) volume (Vs) and Cl content. Vs was calculated based on the dilution of an impermeable marker, [3H]inulin, during harvesting of ASF from xenografts with an isosmotic Cl-free solution. These calculations demonstrated that Vs in CF xenographs (28 +/- 3.0 microliter/cm2; n = 17) was significantly less than that of non-CF xenografts (35 +/- 2. 4 microliter/cm2; n = 30). The Cl concentration of ASF ([Cl]s) was determined using a solid-state AgCl electrode and adjusted for dilution during harvesting using the impermeable [3H]inulin marker. Cumulative results demonstrate small but significant elevations (P < 0.045) in [Cl]s in CF (125 +/- 4 mM; n = 27) compared with non-CF (114 +/- 4 mM; n = 48) xenografts. To investigate potential mechanisms by which CF airways may facilitate a higher level of fluid absorption yet retain slightly elevated levels of Cl, we sought to evaluate the capacity of CF and non-CF airways to absorb both 22Na and 36Cl. Two consistent findings were evident from these studies. First, in both CF and non-CF xenografts, 22Na and 36Cl were always absorbed in an equal molar ratio. Second, CF xenografts hyperabsorbed ( approximately 1.5-fold higher) both 22Na and 36Cl compared with non-CF xenografts. These results substantiate previously documented findings of elevated Na absorption in CF airways and also suggest that the slightly elevated [Cl]s found in this study of CF xenograft epithelia does not occur through a mechanism of decreased apical permeability to Cl.
Similar articles
-
In vivo analysis of fluid transport in cystic fibrosis airway epithelia of bronchial xenografts.Am J Physiol. 1996 May;270(5 Pt 1):C1326-35. doi: 10.1152/ajpcell.1996.270.5.C1326. Am J Physiol. 1996. PMID: 8967432
-
Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.Hum Gene Ther. 1998 Mar 20;9(5):635-48. doi: 10.1089/hum.1998.9.5-635. Hum Gene Ther. 1998. PMID: 9551612
-
Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis.J Clin Invest. 1995 Dec;96(6):2997-3004. doi: 10.1172/JCI118372. J Clin Invest. 1995. PMID: 8675672 Free PMC article.
-
Adenosine receptors, cystic fibrosis, and airway hydration.Handb Exp Pharmacol. 2009;(193):363-81. doi: 10.1007/978-3-540-89615-9_12. Handb Exp Pharmacol. 2009. PMID: 19639288 Review.
-
Chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia.Am J Physiol. 1992 Jul;263(1 Pt 1):L1-14. doi: 10.1152/ajplung.1992.263.1.L1. Am J Physiol. 1992. PMID: 1322048 Review.
Cited by
-
Terminal glycosylation and disease: influence on cancer and cystic fibrosis.Glycoconj J. 2000 Jul-Sep;17(7-9):617-26. doi: 10.1023/a:1011034912226. Glycoconj J. 2000. PMID: 11421353 Review.
-
Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.Glycoconj J. 2001 Sep;18(9):661-84. doi: 10.1023/a:1020867221861. Glycoconj J. 2001. PMID: 12386453 Review.
-
The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11614-9. doi: 10.1073/pnas.97.21.11614. Proc Natl Acad Sci U S A. 2000. PMID: 11027360 Free PMC article.
-
Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8822-8. doi: 10.1073/pnas.97.16.8822. Proc Natl Acad Sci U S A. 2000. PMID: 10922041 Free PMC article. Review.
-
Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.Antimicrob Agents Chemother. 2016 Apr 22;60(5):2813-21. doi: 10.1128/AAC.00157-16. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26902766 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical